BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 949550)

  • 1. Molecular and cellular effects of antisickling concentrations of alkylureas.
    Elbaum D; Roth EF; Neumann G; Jaffé ER; Bookchin RM; Nagel RL
    Blood; 1976 Aug; 48(2):273-82. PubMed ID: 949550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alkylureas on the polymerization of hemoglobin S.
    Elbaum D; Nagel RL; Bookchin RM; Herskovits TT
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4718-22. PubMed ID: 4531011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand kinetics of hemoglobin S containing erythrocytes.
    Harrington JP; Elbaum D; Bookchin RM; Wittenberg JB; Nagel RL
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):203-6. PubMed ID: 264675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of HB S gelation. Effect of alkylureas, ionic strength and other hemoglobins.
    Elbaum D; Harrington JP; Bookchin RM; Nagel RL
    Biochim Biophys Acta; 1978 Jun; 534(2):228-38. PubMed ID: 667101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of urea on sickling.
    May A; Huehns ER
    Br J Haematol; 1975 May; 30(1):21-9. PubMed ID: 1191570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on the effect of CO2 and temperature on the sickling phenomenon.
    Rampling MW
    Eur J Clin Invest; 1975 Sep; 5(5):385-9. PubMed ID: 241649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisickling effect of chrysin is associated with modulation of oxygenated and deoxygenated haemoglobin via alteration of functional chemistry and metabolic pathways of human sickle erythrocytes.
    Nwankwo HC; Idowu AA; Muhammad A; Waziri AD; Abubakar YS; Bashir M; Erukainure OL
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S108-S124. PubMed ID: 34151613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced oxidative denaturation of hemoglobin.
    Nagel RL; Ranney HM
    Semin Hematol; 1973 Oct; 10(4):269-78. PubMed ID: 4610751
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of alkylureas and nitrogen mustards on the kinetics of red cell sickling.
    Harrington JP; Nagel RL
    J Lab Clin Med; 1977 Nov; 90(5):863-72. PubMed ID: 908874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sickle erythrocyte in double jeopardy: autoxidation and iron decompartmentalization.
    Hebbel RP
    Semin Hematol; 1990 Jan; 27(1):51-69. PubMed ID: 2405496
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
    Ueno H; Yatco E; Benjamin LJ; Manning JM
    J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of alkylureas and alkylamides on the gelation of hemoglobin S.
    Herskovits TT; Elbaum D
    Biochim Biophys Acta; 1980 Mar; 622(1):36-51. PubMed ID: 7362836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of sickle hemoglobin by acetaldehyde and its effect on oxygenation, gelation and sickling.
    Abraham EC; Stallings M; Abraham A; Garbutt GJ
    Biochim Biophys Acta; 1982 Jul; 705(1):76-81. PubMed ID: 7115734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethyl adipimidate: a new antisickling agent.
    Lubin BH; Pena V; Mentzer WC; Bymun E; Bradley TB; Packer L
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):43-6. PubMed ID: 1054514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Devlin MT; Schwartz E
    Biochim Biophys Acta; 1981 May; 668(3):397-405. PubMed ID: 7236716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?
    Oder E; Safo MK; Abdulmalik O; Kato GJ
    Br J Haematol; 2016 Oct; 175(1):24-30. PubMed ID: 27605087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
    Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
    Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.